Cutaneous Graft Versus Host Disease Nailfold Videocapillaroscopy

Overview

About this study

The purpose of this study isl to evaluate patients with cutaneous  Graft Versus Host Disease (GVHD) with nailfold capillaroscopy to report on observable changes to the microvasculature.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of cutaneous GVHD based on pathology.

Exclusion Criteria: 

  • Current smoker.
  • Type 2 diabetes.
  • History of Raynaud’s phenomenon or disease.
  • Dialysis dependence.
  • Diagnosis of scleroderma or other connective tissue disease.
  • Recent hand trauma or manicure (< 2 weeks).
  • History of acrocyanosis or erythromelalgia.
  • Previous diagnosis of a bleeding disorder.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 7/19/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Olayemi Sokumbi, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions